ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1912

Meteorological Variables Have Different Effect on Core Measures of Disease Activity in Patients with Rheumatoid Arthritis

Peter Mandl1, Paul Studenic2, Farideh Alasti1, Rainer Kaltenberger3, Andreas Kerschbaumer1, Thomas Krennert3, Josef Smolen1 and Daniel Aletaha4, 1Medical University of Vienna, Vienna, Austria, 2Karolinska Institute; & Medical University of Vienna, Stockholm, Sweden, 3Central Institute for Meteorology and Geodynamics, Vienna, Austria, 4Medical University Vienna, Vienna, Austria

Meeting: ACR Convergence 2021

Keywords: Disease Activity, longitudinal studies, pain, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: Abstracts: Patient Outcomes, Preferences, & Attitudes (1909–1914)

Session Type: Abstract Session

Session Time: 2:45PM-3:00PM

Background/Purpose: The notion that weather conditions may influence the symptoms and course of rheumatic and musculoskeletal diseases goes back to ancient times. We aimed to evaluate whether meteorological variables influence disease activity in patients with rheumatoid arthritis (RA).

Methods: We assessed the correlation between individual meteorological variables: temperature, effective temperature, saturation vapor pressure, absolute humidity, relative humidity, dew point, precipitation and clinical measures of disease activity: simplified disease activity index (SDAI), self-reported pain, patient’s global assessment (PGA), 28 tender joint count (TJC) and 28 swollen joint count (SJC). Assessments documented in the Care for RA database were matched with weather variables on a daily basis for a period of 12 years between 2005 and 2017, and analyzed using generalized estimating equations (longitudinal data analysis). Patients with < 5 visits in the study period, those with < 1 visit/quarter or with pain=0 in ≥3 consecutive visits and those living outside of the catchment area were excluded.

Patients were grouped into low (≤11) vs. moderate/high ( >11) disease activity based on SDAI, and additionally considering only subsequent outpatient visits ( >3 visits) where the therapy was stable ( >6 months). On this basis three treatment groups were established: patients taking (1) methotrexate, (2) csDMARD or (3) bDMARD in mono- or combination therapy respectively.

Results: A total of 461 patients with an average disease duration at first visit of 5.7±7.4 years, age of 55.3±14.5 years, mean SDAI: 22.1±12.7 were analyzed. Among patients with moderate/high disease activity, higher temperature/effective temperature and saturation vapor pressure were associated with lower pain and TJC. On the contrary, higher relative humidity was associated with higher pain and higher SJC. Among patients with low disease activity higher relative humidity, absolute humidity, vapor pressure or dew point were associated with lower PGA. Higher precipitation was associated with lower SJC in the low disease activity group (Figure 1). When analysed according to stable treatment period, patients treated with csDMARD in mono- or combination therapy showed the same association between higher average daily temperature/effective temperature or saturation vapor pressure and lower pain as seen in patients with moderate/high disease activity (Figure 2).

Conclusion: In this largest association study of meteorological parameters with RA, both temperature and humidity were shown to have significant effects on pain, TJC and SJC, while PGA was mostly influenced by humidity. Weather had different effects depending on RA disease activity.

Figure 1. Association of meteorological variables and clinical measures of disease activity. PGA: patient’s global assessment; SDAI: simplified disease activity index; SJC: swollen joint count; TJC: tender joint count; * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001.

Figure 2. Association of meteorological variables and clinical measures of disease activity in stable therapy periods. csDMARD: conventional synthetic disease modifying anti-rheumatic drug; MTX: methotrexate; PGA: patient’s global assessment; SDAI: simplified disease activity index; SJC: swollen joint count; TJC: tender joint count; * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.001.


Disclosures: P. Mandl, MSD, 5, 6, Celgene, 5, 6, Lilly, 5, 6, BMS, 5, 6, AbbVie, 5, 6, Janssen, 5, 6, Novartis, 5, 6, Roche, 5, 6, UCB, 5, 6; P. Studenic, None; F. Alasti, None; R. Kaltenberger, None; A. Kerschbaumer, ABBVIE, 2, bristol-meyers squibb, 2, celgene, 2, Eli Lilly, 2, gilead, 2, Merck Sharp and Dohme, 2, Novartis, 2, Pfizer, 2; T. Krennert, None; J. Smolen, AbbVie, 2, 5, BMS, 2, 5, Celegene, 2, 5, Chugai, 2, 5, Gilead, 2, 5, Janssen, 2, 5, Eli Lilly, 2, 5, MSD, 2, 5, Novartis-Sandoz, 2, 5, Pfizer, 2, 5, Roche, 2, 5, Samsung, 2, 5, Sanofi, 2, 5, UCB, 2, 5; D. Aletaha, AbbVie, 2, 5, Janssen, 2, 5, Medac, 2, 5, Merck, 2, 5, 6, Pfizer, 2, 5, Roche, 2, 5, UCB, 2, 5, Novartis, 2, 5, 6, Bristol-Myers Squibb, 6, Amgen, 2, 6, Celgene, 2, 6, Eli Lilly, 2, 6.

To cite this abstract in AMA style:

Mandl P, Studenic P, Alasti F, Kaltenberger R, Kerschbaumer A, Krennert T, Smolen J, Aletaha D. Meteorological Variables Have Different Effect on Core Measures of Disease Activity in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/meteorological-variables-have-different-effect-on-core-measures-of-disease-activity-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/meteorological-variables-have-different-effect-on-core-measures-of-disease-activity-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology